The price is right There's been a slow start to EU discussions on pharma pricing, but will GlaxoSmithKilne's 'price-sharing' scheme spearhead an industry-wide initiative? Lynne Taylor reports Upsetting the apple cart Mark Greener unpicks Pfizer's move to secure the wholesale supply chain, and finds it provoked an almighty row
Clearing the dark clouds The global pharmaceutical industry is striving to improve its reputation. Ian Hall, who covers the pharmaceutical sector as News Editor of PRWeek, assesses a work in progress.
Subscription is free to UK subscribers.
To read all the articles and features in the magazine, why not subscribe?
